News About: Pharm. Industry
Number of hospital calls and treatments per capita was 13 in 2001.
The National Health Insurance Corporation reported in "2001 NHI statistics" that the total number of NHI beneficiary was 46 million in 2001, of which 39 million people took service benefits at hospitals or clinics, sh...
Chongkundang jointly to develop DDS oral antibiotics.
Chongkundang announced to ink an agreement with Dasan Medichem, a drug dosage form research specialized venture company, on Oct. 24 for the joint development of an oral DDS antibiotic.
Dasan will apply the fine par...
Post supervision on drug quality controls found loosen.
It is pointed out that the recent outbreak of drug incidences caused by the drug quality defects and manufacturing malpractices was an already predicted mishap resulting from the government's poor supervisory controls...
Biopol to export Mediform to Southeast countries
Biopol, a start-up company, announced on October 21 that it plans to export US$17.5 million worth of closed wet dressing (sponge-type gauze) through its recent agreement with Zhende Co. of China (US$ 10 million) and S...
KPMA suggests drug companies to activate OTC advertising.
As a result of the government's ongoing drug price slashes, the drug industry has faced with serious profit deteriorations. To overcome the difficult situation, the industry has no other choice but to look at an activ...
Bulk drug imported from Japan recorded top in first half of this year.
Japan was found as the top import source of pharmaceutical bulk materials during the first half of this year Japanese according to the 2002 KFDA statistics. The total bulk materials imported from 57 nations including ...
KFDA to suspend production of Galamin, etc.
The KFDA said it discovered some defects in Kuhnpoong Pharm's manufacturing facilities for injectables with the mixing problems of foreign materials as a results of its special inspection and called for the competent ...
LG Life Science to export Factive technologyLG Life Science said on October 22 that it signed with GeneSoft, an US bioventure firm, a strategic alliance agreement for the marketing of a novel quinolone antibiotic Factive ...
|
Economic uneasiness contributes to expansion of domestic anti-anxietic market
Pharmaceutical business sources forecast that the domestic market for anti-anxietic drugs is likely to be further expanded, in the wake of the overall political and economic unrest at home and abroad.
After Korea's...
Financially battered drug companies successfully survived.
During the IMF financial crisis in 1997 several domestic drug corporations were drowned into a deep swamp including a court control or a workout establishment but gradually restoring their competence now almost to qui...
